Climb Bio, Inc.
Nasdaq CLYM · Wellesley Hills, MA
Works in Dermatology · Hematology · Immunology · Renal & urogenital · Women's health
Climb Bio, Inc. is a clinical trial sponsor based in Wellesley Hills, MA, listed as Nasdaq CLYM. It has 5 active clinical trials with 177 planned participants, across 5 therapeutic areas. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq CLYM
Fundraising
Pipeline · 5 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Climb Bio, Inc
Climb Bio, Inc is lead sponsor of 5 active clinical trials on ClinicalTrials.gov, with 177 planned participants, in Dermatology, Hematology, Immunology, Renal & urogenital and other areas. Since 2021 it has completed 1 trial and stopped 0 early.
Climb Bio, Inc is based in Wellesley Hills, MA and is listed as Nasdaq CLYM. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Climb Bio, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-08.
Approve Suite is not affiliated with Climb Bio, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.